Aslan Pharmaceuticals Price on April 22, 2024

ASLNDelisted Stock  USD 0.60  0.03  4.76%   
If you're considering investing in Aslan Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aslan Pharmaceuticals stands at 0.60, as last reported on the 12th of December 2024, with the highest price reaching 0.70 and the lowest price hitting 0.60 during the day. We have found twenty-four technical indicators for Aslan Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please confirm Aslan Pharmaceuticals' Risk Adjusted Performance of (0.17), mean deviation of 5.79, and Standard Deviation of 9.4 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Aslan Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ASLN
Based on monthly moving average Aslan Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aslan Pharmaceuticals by adding Aslan Pharmaceuticals to a well-diversified portfolio.

Related Headline

Agios Pharm Headline on 22nd of April 2024

Filed transaction by Agios Pharm Director, Officer Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3

Aslan Pharmaceuticals Valuation on April 22, 2024

It is possible to determine the worth of Aslan Pharmaceuticals on a given historical date. On April 22, 2024 Aslan was worth 4.64 at the beginning of the trading date compared to the closed value of 3.64. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aslan Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Aslan Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aslan Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aslan Pharmaceuticals' related companies.
 Open High Low Close Volume
  4.19    4.56    4.01    4.10    3,251  
04/22/2024
  4.64    4.90    3.44    3.64    1,422,850  
  3.58    4.16    3.56    3.75    189,626  
Backtest Aslan Pharmaceuticals  |  Aslan Pharmaceuticals History  |  Aslan Pharmaceuticals Valuation   PreviousNext  
Open Value
4.64
3.64
Closing Value
4.64
Upside

Aslan Pharmaceuticals Trading Date Momentum on April 22, 2024

On April 23 2024 Aslan Pharmaceuticals was traded for  3.75  at the closing time. The top price for the day was 4.16  and the lowest listed price was  3.56 . The trading volume for the day was 189.6 K. The trading history from April 23, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 3.02% . The overall trading delta against the current closing price is 1.92% .

Aslan Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Aslan Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aslan Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aslan financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Aslan Pharmaceuticals Stock history

Aslan Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aslan is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aslan Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aslan Pharmaceuticals stock prices may prove useful in developing a viable investing in Aslan Pharmaceuticals
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company was founded in 2010 and is headquartered in Singapore. Aslan Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 27 people.

Aslan Pharmaceuticals Stock Technical Analysis

Aslan Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Aslan Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aslan Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Aslan Pharmaceuticals Period Price Range

Low
December 12, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Aslan Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Aslan Pharmaceuticals December 12, 2024 Market Strength

Market strength indicators help investors to evaluate how Aslan Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aslan Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Aslan Pharmaceuticals stock market strength indicators, traders can identify Aslan Pharmaceuticals entry and exit signals to maximize returns

Aslan Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Aslan Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Aslan Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aslan to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in Aslan Stock

If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine